ORX142 Tablets
ORX142-0101
Phase 1 small_molecule active
Quick answer
ORX142 Tablets for Excessive Daytime Sleepiness is a Phase 1 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Centessa Pharmaceuticals plc
- Indication
- Excessive Daytime Sleepiness
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active